Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model

Area of Science:

• Pharmacology
• Genetics
• Toxicology

Background:

• Cytochrome P450 (CYP) enzymes are crucial for drug metabolism and chemical detoxification.
• Targeted knockout mouse models are essential tools for elucidating CYP gene functions.
• Previous models have limitations in comprehensively studying specific CYP gene clusters.

Purpose of the Study:

• To generate and characterize a novel mouse model with a targeted deletion of a nine-gene cluster on mouse chromosome 7, including multiple Cyp2a and Cyp2b genes.
• To assess the impact of this gene deletion on drug metabolism and enzyme activity in various tissues.
• To establish a valuable resource for in vivo studies of xenobiotic metabolism and toxicity.

Main Methods:

• Generation of a Cyp2a(4/5)bgs-null mouse strain using Cre-mediated recombination in vivo.
• Confirmation of gene and mRNA deletion via polymerase chain reaction (PCR) analysis.
• Measurement of microsomal testosterone hydroxylation activity and pentobarbital clearance in knockout versus wild-type mice.

Main Results:

• The novel Cyp2a(4/5)bgs-null mouse model was viable and fertile with no observed developmental abnormalities.
• Significant reductions in microsomal testosterone hydroxylation activity were observed in multiple tissues, including olfactory mucosa, lung, liver, and brain.
• A >60% increase in pentobarbital-induced sleeping time indicated decreased systemic clearance in knockout mice compared to wild-type.

Conclusions:

• The generated Cyp2a(4/5)bgs-null mouse model is a robust tool for investigating the in vivo roles of deleted CYP genes in drug metabolism and chemical toxicity.
• This model facilitates research in diverse tissues expressing the targeted CYP genes.
• The model offers potential for creating humanized mouse models for specific human CYP enzymes and serves as a knockout for linked non-P450 genes.